ICPC recognizes early detection and screening as critical pillars in the fight against cancer. Timely identification of cancer not only saves lives but also reduces the financial and emotional toll on patients, families, and healthcare systems. However, disparities in access to screening programs, particularly in low- and middle-income countries, leave many at risk of late-stage diagnoses.
In the video below, filmed during ICPC’s event in Barcelona, you can listen to Dr. Tanya Hills, Global Patient Engagement Lead at Boehringer Ingelheim, give important insights on the topic and explore more the critical role of early detection and screening in cancer care. In her interview, Dr. Hills highlights the latest innovations in cancer diagnostics and addresses ongoing challenges in early detection. She emphasizes the transformative impact of advanced diagnostic tools in improving patient survival rates and reducing the burden of late-stage diagnoses.
This perspective underscores the urgency of equitable access to effective screening programs worldwide.
ICPC advocates for accessible, inclusive, and culturally sensitive screening programs that empower individuals through education and awareness. By fostering collaboration among healthcare systems, patient organizations, and policymakers, ICPC works to ensure that all communities have access to effective early detection methods.
ICPC also emphasizes the importance of equity in screening access, particularly for cancers with proven benefits of early detection, such as breast, cervical, colorectal, and lung cancers. It supports initiatives aimed at strengthening healthcare system readiness for screening programs, integrating cutting-edge technologies like AI-powered diagnostics, and promoting risk-based approaches tailored to regional and demographic needs.
The coalition is committed to closing the gap in cancer prevention by promoting policies and practices that prioritize screening access and reduce barriers such as cost, health literacy, and infrastructure limitations.
